Interest Expense in USD of Barinthus Biotherapeutics plc. from Q3 2020 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Barinthus Biotherapeutics plc. quarterly/annual Interest Expense history and change rate from Q3 2020 to Q1 2024.
  • Barinthus Biotherapeutics plc. Interest Expense for the quarter ending 31 Mar 2024 was $12K.
  • Barinthus Biotherapeutics plc. annual Interest Expense for 2023 was $28K, a 47.4% increase from 2022.
  • Barinthus Biotherapeutics plc. annual Interest Expense for 2022 was $19K, a 99.3% decline from 2021.
  • Barinthus Biotherapeutics plc. annual Interest Expense for 2021 was $2.67M, a 25.9% decline from 2020.
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Change (%)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Change (%)

Barinthus Biotherapeutics plc. Quarterly Interest Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $12K +$12K 01 Jan 2024 31 Mar 2024 10-Q 13 May 2024
Q1 2023 $0 -$74K -100% 01 Jan 2023 31 Mar 2023 10-Q 13 May 2024
Q1 2022 $74K -$2.58M -97.2% 01 Jan 2022 31 Mar 2022 10-Q 12 May 2023
Q1 2021 $2.65M 01 Jan 2021 31 Mar 2021 10-Q 11 May 2022
Q3 2020 $969K 01 Jul 2020 30 Sep 2020 10-Q 12 Nov 2021

Barinthus Biotherapeutics plc. Annual Interest Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $28K +$9K +47.4% 01 Jan 2023 31 Dec 2023 10-K 20 Mar 2024
2022 $19K -$2.65M -99.3% 01 Jan 2022 31 Dec 2022 10-K 20 Mar 2024
2021 $2.67M -$932K -25.9% 01 Jan 2021 31 Dec 2021 10-K 24 Mar 2023
2020 $3.6M 01 Jan 2020 31 Dec 2020 10-K 25 Mar 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.